Vera Gorbunova, PhD
Doris Johns Cherry Professor; Professor of Biology; Co-director, Rochester Aging Research Center
Speaker at DoNotAge Conference 2026.
Research profileBiohack Blueprint · DoNotAge Intelligence
A source-linked directory of scientists, investigators, speakers and institutions connected to DoNotAge conferences, grants, trials and research projects. Inclusion describes a verified relationship; it does not imply endorsement.
Key points
These statements define the scope of the directory and the limits of what its relationships mean.
People & institutions
Inclusion documents a specific public relationship. It does not imply endorsement, employment or advisory status unless the cited relationship establishes that role.
Doris Johns Cherry Professor; Professor of Biology; Co-director, Rochester Aging Research Center
Speaker at DoNotAge Conference 2026.
Research profileDean’s Professor; Professor of Biology; Co-director, Rochester Aging Research Center
Speaker at DoNotAge Conference 2026.
Research profileResearch Assistant; PhD Student
DoNotAge Conference 2026 speaker. The official conference archive describes an ongoing older-adult muscle-regeneration study comparing DoNotAge Pure Spermidine with placebo; DoNotAge support is listed as research ingredients and matching placebo.
Research profilePresident
DoNotAge Conference 2026 speaker and lead of an ICR/Unicamp preclinical replication project to which DoNotAge contributed US$25,000. Cherñavsky also co-authored a separate 2025 peer-reviewed acute feasibility/safety study of young-pig-plasma extracellular particles in young rats; that paper is not rejuvenation-efficacy evidence.
Research profilePhD Student
DoNotAge Conference 2026 speaker and recipient of a DoNotAge.org-BSRA Small Research Grant. The DoNotAge-BSRA award supports Ward's cardiovascular-inflammation research programme; it is distinct from the funding listed for the registered icosapent-ethyl study, whose protocol names Amarin Global and the University of Lincoln.
Research profileProfessor of Nutritional Sciences
DoNotAge Scientific Advisory Board member and DoNotAge Conference 2026 speaker. In a DoNotAge video, Ostojic also outlined a planned 24-week older-adult clinical study of the multi-ingredient DoNotAge Performance formulation; the later conference archive described the research as ongoing.
Research profilePhD Researcher
DoNotAge Conference 2026 speaker. The official conference archive describes DoNotAge support for her PhD research and reports a human exercise study using DoNotAge Pure Quercetin.
Research profileAssistant Professor of Gerontology
DoNotAge Conference 2026 speaker. Conference materials report DoNotAge funding for a prospective aged-mouse PS18-versus-exercise study. Cortes' earlier published muscle-to-brain and skeletal-muscle TFEB studies are separate mechanistic research and should not be represented as DoNotAge-funded PS18 efficacy studies.
Research profileProfessor in Exercise and Health Sciences
DoNotAge Conference 2026 speaker and co-presenter of the conference-reported 20-day Pure Quercetin versus placebo study. The related registered study NCT06230861 lists DoNotAge.org as a collaborator.
Research profileResearcher and clinical-study responsible party
Speaker at DoNotAge Conference 2026; responsible party for ClinicalTrials.gov study NCT06230861, which lists DoNotAge.org as a collaborator.
Relationship sourceProfessor
Speaker at DoNotAge Conference 2026.
Relationship sourceLecturer in Host/Pathogen Interactions
DoNotAge Conference 2026 speaker. No separate DoNotAge-funded Rebecca Sumner research project was independently identified in the reviewed sources as of October 10, 2026.
Research profileFounder & Clinical Research Advisor
Founder and Clinical Research Advisor at DoNotAge.org; DoNotAge Conference 2026 speaker discussing the organisation's research-support relationships, including human studies, laboratory research, replication work, PhD projects and provision of research ingredients and matching placebos.
Research profile